Pharmacia & Upjohn Co. LLC, a subsidiary of Pfizer Inc., is a company headquartered in Bingham Farms, MI, that manufactures and supplies pharmaceutical goods.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Symed Laboratories Ltd., part of Viyash Life Sciences Pvt Ltd., is an Indian company located in Hyderabad. The firm manufactures pharmaceutical ingredients. It was founded in 1997. Mohan Rao Dodda is currently the CEO of the company. Viyash Life Sciences Pvt Ltd. acquired Symed Laboratories Ltd. on July 31, 2021.

Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.

ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases. It addresses multi-drug resistant infections using therapeutic products from its lysin and monoclonal antibody platforms to target the conserved regions of either bacteria or viruses. Its novel lysins are enzymes that are produced in the life cycle stage of bacteriophage, a virus that infects and kills bacteria. The company was founded in 2008 and is headquartered in Yonkers, New York.

Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ.

Optimus Drugs Pvt Ltd. engages in the manufacture of pharmaceutical products. It offers antihyperparathyroid, antidepressant, antifungal, antithrombotic, anticonvulsant, antibacterial, antipsychotic, antiretroviral, protease inhibitor, and aldosterone antagonist. The company was founded by Srinivasa Reddy in 2004 and is headquartered in Hyderabad, India.

Good health and a happy life is something all people rightly aspire to. They believe everyone on the planet deserves access to quality health care. Finding affordable solutions to today's health care challenges demands cutting-edge science, highly talented and motivated people and above all the ability to innovate. Innovation and continuous improvement are the heartbeat of their company. Their mission is to make health care more affordable, increasing access to important medicines through the provision of high quality small molecule generics, and new biological and new chemical entities.

The legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India. The publicly listed entity that manufactures and markets generic pharmaceutical products across the globe has grown by leaps and bounds over the last century. With an emphasis on innovation and technology, the company has established a state-of-the-art research facility – Alembic Research Centre (ARC)-including formulation research, and 150-bed bioequivalence facility at Vadodara, Gujarat. Additionally, APL has recently invested in ultra-modern R&D center at Hyderabad. APL is one of the leading players in the industry to have invested about 11% of its turnover in R&D. As a growth strategy, the company has aggressively started investing in the international generics market with successful ANDA and DMF filings. APL has also filings across Canada, Europe, Australia, South Africa & Brazil. The company caters to the rest of the world markets through branded formulation sales. The company aims to explore opportunities in the therapeutic areas such as Dermatology, Oncology, and Injectable Formulations. APL also has also co-promoted a company focused on discovery and development of innovative, small molecule drugs that target signal transduction networks and ion channels for the treatment of cancer, inflammation, autoimmune diseases and metabolic disorders.

Panacea Biotec is an Innovation driven Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals, Vaccines and Biosimilars. Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited with a commitment to make Innovative Products Affordable and Accessible to the masses. It got publically listed on Indian National Stock Exchanges in September 1995 as Panacea Biotec Ltd. Panacea Biotec is witnessing a period of expansion across every aspect of their business from innovative products to customers in market, from manufacturing to regulatory approvals and thereby laying the foundation for translation of their vision in becoming greatest, largest and most admired biotechnology company in the World by 2020. Ardent Research and Development efforts have always been a great strength of Panacea Biotec. The main research areas are New Chemical Entities (NCE), New Biological Entities (NBE) Novel Drug Delivery System (NDDS) based pharmaceutical formulations, Novel peptides & human monoclonal antibodies and Vaccine development. The company has developed four distinguished, ultra-modern, state-of-art R&D centres in different locations, having internal capabilities for constant research, with over 300 highly professional and skilled scientists engaged in various aspects of research.

Lee Pharma manufactures intermediate chemicals, active pharmaceutical ingredients, semi-finished dosage forms, and finished formulations. They focus on the development, synthesis, and commercialization of new products and cost-effective processes.

Part of Hansoh Pharmaceutical Group Co., Ltd., Jiangsu Hansoh Pharmaceutical Co. Ltd. is a company headquartered in Jiangsu, China, that manufactures and distributes pharmaceutical products.

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research & development, manufacture, and sale of pharmaceutical products as well as veterinary medicines. Its products include active pharmaceutical ingredients and generic drugs. The company was founded in 1956 and is headquartered in Taizhou, China.

Lianhetech is a leading solution & service provider for chemistry and technology focusing on four global markets: At Lianhetech, we are dedicated to providing innovative and highly integrated chemistry based solutions throughout the life cycle of our client’s products. We always strive to achieve the highest level of customer satisfaction from development to commercialization. To ensure customer success we are committed to close collaboration throughout the entire product life cycle.Since 1985, Lianhetech has established seven chemical production sites and two machinery production sites as well as two R&D centers in China. Lianhetech has enjoyed strong business growth, and today we are still driven by our customer’s success in the market.We firmly believe that success for a chemical company is not defined by business growth alone, but also by actively contributing to society and the environment. Lianhetech is committed to being a highly responsible corporate citizen that adheres to the highest industry standards. Safety, health, environment, quality, and compliance, are all of the utmost importance to us.

Boulos & Cooper Pharmaceuticals is a proprietary company focused on the development of a new class of antibiotics with novel targets. Being a pioneer in the field, the company wholly owns a strong and expanding IP portfolio with patents granted in AU and the US in addition to a number of other provisional and PCT filings. The pharmaceutical company established a framework with a number of industry partners for the development of its key areas of research, operating leanly, and maximizing investment in research. They are proud of their progress and achievements to date and they remain focussed on the work ahead and believes that innovative and promising technologies are the key to creating true value for their investors. It was incorporated by Dr. Ramiz Boulos in 2013 and is based in Perth, Western Australia.

Jubilant Life Sciences Limited, is an integrated global pharmaceutical and life sciences company.Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Other businesses including Drug Discovery & Development Solutions and India Branded Pharmaceuticals. The Pharmaceuticals segment, through its wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacturing and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-sterile products through 6 USFDA approved manufacturing facilities in the US, Canada and India and a network of over 50 radio-pharmacies in the US. The Life Science Ingredients segment, is engaged in Specialty Intermediates, Nutritional Products and Life Science Chemicals through 5 manufacturing facilities in India. The Drug Discovery & Development Solutions business, provides proprietary in-house innovation & collaborative research and partnership for out-licensing through 2 world class research centers in India. Jubilant Life Sciences Limited has a team of around 7,700 multicultural people across the globe and is committed to deliver value to its customers across over 100 countries. The Company is well recognized as a ‘Partner of Choice’ by leading pharmaceuticals and life sciences companies globally.

Dipharma is a European manufacturer of Active Pharmaceutical Ingredients that has been developing innovative and proprietary processes since 1949. We support our customers worldwide with a strong and well resourced R&D team, three cGMP facilities in Europe, and offer world-renowned expertise in handling hazardous chemical processes. Our customers can benefit from our broad portfolio of generic Active Pharmaceutical Ingredients and a wide range of advanced technologies available for custom synthesis. They can rely on the highest quality standards, but it does not stop there, they can count on our experience in innovation.